Natalizumab [189261-10-7]
M24843
Product group Antibodies
Overview
- SupplierAbMole BioScience
- Product NameNatalizumab [189261-10-7]
- Delivery Days Customer7
- CAS Number189261-10-7
- CertificationResearch Use Only
- Estimated Purity≥99.0%
- Scientific DescriptionNatalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to alfa4bèta1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses.
- Storage InstructionPlease store the product under the recommended conditions in the Certificate of Analysis.
- UNSPSC41116161
![Natalizumab [189261-10-7]](https://www.targetmol.com/group3/M00/12/C6/CgoaEGZGsDiETscuAAAAAMuSyx8331.png)
